- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 05.02. | Astellas takes $760M charge, reveals slowdown for eye drug Izervay after regulatory stumbles | ||
| 05.02. | TV drug ad spending reached new heights in January, as Novartis' Pluvicto toppled AbbVie's Skyrizi for top spot | ||
| 05.02. | Avalere refocuses on ensuring access to care under new CEO | ||
| 05.02. | Novo Nordisk predicts milder growth in 2025 after obesity star Wegovy doubles sales in Q4 | ||
| 05.02. | With recent launches and more to come, Amgen's biosimilar business is trending up | ||
| 05.02. | With Blenrep's revival, GSK dials up long-term sales goal-again-despite RSV vaccine woes | ||
| 05.02. | Moderna picks Merck KGaA, Roivant alum as marketing chief | ||
| 05.02. | CDC Foundation taps ex-NFL star 'The Bus' to drive home heart health message in Black community | ||
| 04.02. | Roche gains label expansion for eye implant Susvimo to treat diabetic macular edema | ||
| 04.02. | Bristol Myers Squibb, Kyowa Kirin layoffs hit 119 in New Jersey amid separate restructuring campaigns | ||
| 04.02. | Merck halts Gardasil shipments to China, withdraws $11B sales target as demand nosedives | ||
| 04.02. | World Cancer Day 2025: Merck, Pfizer, GSK among pharmas raising awareness of prevention, detection, treatment options | ||
| 03.02. | RFK Jr.'s nomination for HHS secretary clears Senate committee, teeing up full vote | ||
| 03.02. | Valneva snares $33M contract to supply US with Japanese encephalitis vaccine | ||
| 03.02. | Alvogen recalls fentanyl patches due to possible overdose risk | ||
| 03.02. | Thermo Fisher's layoff spree continues with 300 dismissals in Massachusetts | ||
| 03.02. | Pfizer's Braftovi combo on track for full approval in win for FDA's Project FrontRunner | ||
| 31.01. | AbbVie jacks up 2027 sales projection for star duo of Skyrizi, Rinvoq to $31B | ||
| 31.01. | Novartis' Kisqali off to 'very rapid' launch in early breast cancer, CEO says. Can it keep up the momentum? | ||
| 31.01. | Eylea-Vabysmo battle wages on as UK marketing watchdog reaffirms Bayer's claims of 'misleading' Roche promos | ||
| 31.01. | Merck vaccine, Daiichi ADC win approval recommendations in busy week at EU's drug regulator | ||
| 31.01. | Analysts tip thyroid disorder awareness push to boost health outcomes, market growth | ||
| 31.01. | AstraZeneca scraps £450M expansion at UK vaccine plant, citing reduced government contribution | ||
| 31.01. | Axsome secures hard-fought FDA nod for rapid-acting migraine drug Symbravo | ||
| 30.01. | RFK Jr. wades through Senate HELP committee's vaccine concerns in second confirmation hearing |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
